Characterization of epoxyeicosatrienoic acid binding site in U937 membranes using a novel radiolabeled agonist, 20-125I-14,15-epoxyeicosa-8(Z)- enoic acid

Wenqi Yang, Venugopal Raju Tuniki, Siddam Anjaiah, J. R. Falck, Cecilia J. Hillard, William B. Campbell

Research output: Contribution to journalArticle

66 Citations (Scopus)

Abstract

Epoxyeicosatrienoic acids (EETs) are important regulators of vascular tone and homeostasis. Whether they initiate signaling through membrane receptors is unclear. We developed 20-iodo-14,15-epoxyeicosa-8(Z)-enoic acid (20-I-14,15-EE8ZE), a radiolabeled EET agonist, to characterize EET binding to membranes of U937 cells. 20-I-14,15-EE8ZE stimulated cAMP production in U937 cells with similar potency, but it decreased efficacy compared with 11,12-EET. Maximum cAMP production increased 4.2-fold, with an EC50 value of 9 μM. Like 14,15-EET, 20-I-14,15-EE8ZE relaxed bovine coronary arteries, with a similar EC50 value. Both 20-I-14,15-EE8ZE agonist activities were blocked by the EET antagonist 14,15-epoxyeicosa-5(Z)-enoic acid (14,15-EE5ZE). Specific 20-125I-14,15-EE8ZE binding to U937 membranes reached equilibrium within 10 min and remained unchanged for 30 min at 4° C. The binding was saturable, reversible, and exhibited KD and Bmax values of 11.8 ± 1.1 nM and 5.8 ± 0.2 pmol/mg protein, respectively. Pretreatment of the membranes with guanosine 5′-O-(3-thio)triphosphate reduced the Bmax in a concentration-related manner. 20- 125I-14,15-EE8ZE binding was inhibited by eicosanoids with potency order of 11,12-EET >14,15-EE5ZE ≈ 14,15-EET ≫ 15- hydroxyeicosatetraenoic acid > 14,15-EET-thiirane >14,15- dihydroxyeicosatrienoic acid. This order is in agreement with the efficacy and potency of cAMP production. In summary, 20-125I-14,15-EE8ZE is a radiolabeled EET agonist that is useful to study binding and metabolism. Using this radioligand, we have identified a specific high-affinity and high-abundance EET binding site in U937 cell membranes. This binding site could represent a specific EET receptor, which is probably a G protein-coupled receptor.

Original languageEnglish (US)
Pages (from-to)1019-1027
Number of pages9
JournalJournal of Pharmacology and Experimental Therapeutics
Volume324
Issue number3
DOIs
StatePublished - Mar 2008

Fingerprint

U937 Cells
Binding Sites
Acids
Membranes
Guanosine 5'-O-(3-Thiotriphosphate)
Hydroxyeicosatetraenoic Acids
Eicosanoids
G-Protein-Coupled Receptors
Blood Vessels
Coronary Vessels
Homeostasis
Cell Membrane
14,15-epoxy-5,8,11-eicosatrienoic acid
Proteins
14,15-episulfide eicosatrienoic acid
11,12-epoxy-5,8,14-eicosatrienoic acid

ASJC Scopus subject areas

  • Pharmacology

Cite this

Characterization of epoxyeicosatrienoic acid binding site in U937 membranes using a novel radiolabeled agonist, 20-125I-14,15-epoxyeicosa-8(Z)- enoic acid. / Yang, Wenqi; Tuniki, Venugopal Raju; Anjaiah, Siddam; Falck, J. R.; Hillard, Cecilia J.; Campbell, William B.

In: Journal of Pharmacology and Experimental Therapeutics, Vol. 324, No. 3, 03.2008, p. 1019-1027.

Research output: Contribution to journalArticle

Yang, Wenqi ; Tuniki, Venugopal Raju ; Anjaiah, Siddam ; Falck, J. R. ; Hillard, Cecilia J. ; Campbell, William B. / Characterization of epoxyeicosatrienoic acid binding site in U937 membranes using a novel radiolabeled agonist, 20-125I-14,15-epoxyeicosa-8(Z)- enoic acid. In: Journal of Pharmacology and Experimental Therapeutics. 2008 ; Vol. 324, No. 3. pp. 1019-1027.
@article{e9db9e288ede465ab6a18cec4cd0faf6,
title = "Characterization of epoxyeicosatrienoic acid binding site in U937 membranes using a novel radiolabeled agonist, 20-125I-14,15-epoxyeicosa-8(Z)- enoic acid",
abstract = "Epoxyeicosatrienoic acids (EETs) are important regulators of vascular tone and homeostasis. Whether they initiate signaling through membrane receptors is unclear. We developed 20-iodo-14,15-epoxyeicosa-8(Z)-enoic acid (20-I-14,15-EE8ZE), a radiolabeled EET agonist, to characterize EET binding to membranes of U937 cells. 20-I-14,15-EE8ZE stimulated cAMP production in U937 cells with similar potency, but it decreased efficacy compared with 11,12-EET. Maximum cAMP production increased 4.2-fold, with an EC50 value of 9 μM. Like 14,15-EET, 20-I-14,15-EE8ZE relaxed bovine coronary arteries, with a similar EC50 value. Both 20-I-14,15-EE8ZE agonist activities were blocked by the EET antagonist 14,15-epoxyeicosa-5(Z)-enoic acid (14,15-EE5ZE). Specific 20-125I-14,15-EE8ZE binding to U937 membranes reached equilibrium within 10 min and remained unchanged for 30 min at 4° C. The binding was saturable, reversible, and exhibited KD and Bmax values of 11.8 ± 1.1 nM and 5.8 ± 0.2 pmol/mg protein, respectively. Pretreatment of the membranes with guanosine 5′-O-(3-thio)triphosphate reduced the Bmax in a concentration-related manner. 20- 125I-14,15-EE8ZE binding was inhibited by eicosanoids with potency order of 11,12-EET >14,15-EE5ZE ≈ 14,15-EET ≫ 15- hydroxyeicosatetraenoic acid > 14,15-EET-thiirane >14,15- dihydroxyeicosatrienoic acid. This order is in agreement with the efficacy and potency of cAMP production. In summary, 20-125I-14,15-EE8ZE is a radiolabeled EET agonist that is useful to study binding and metabolism. Using this radioligand, we have identified a specific high-affinity and high-abundance EET binding site in U937 cell membranes. This binding site could represent a specific EET receptor, which is probably a G protein-coupled receptor.",
author = "Wenqi Yang and Tuniki, {Venugopal Raju} and Siddam Anjaiah and Falck, {J. R.} and Hillard, {Cecilia J.} and Campbell, {William B.}",
year = "2008",
month = "3",
doi = "10.1124/jpet.107.129577",
language = "English (US)",
volume = "324",
pages = "1019--1027",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "3",

}

TY - JOUR

T1 - Characterization of epoxyeicosatrienoic acid binding site in U937 membranes using a novel radiolabeled agonist, 20-125I-14,15-epoxyeicosa-8(Z)- enoic acid

AU - Yang, Wenqi

AU - Tuniki, Venugopal Raju

AU - Anjaiah, Siddam

AU - Falck, J. R.

AU - Hillard, Cecilia J.

AU - Campbell, William B.

PY - 2008/3

Y1 - 2008/3

N2 - Epoxyeicosatrienoic acids (EETs) are important regulators of vascular tone and homeostasis. Whether they initiate signaling through membrane receptors is unclear. We developed 20-iodo-14,15-epoxyeicosa-8(Z)-enoic acid (20-I-14,15-EE8ZE), a radiolabeled EET agonist, to characterize EET binding to membranes of U937 cells. 20-I-14,15-EE8ZE stimulated cAMP production in U937 cells with similar potency, but it decreased efficacy compared with 11,12-EET. Maximum cAMP production increased 4.2-fold, with an EC50 value of 9 μM. Like 14,15-EET, 20-I-14,15-EE8ZE relaxed bovine coronary arteries, with a similar EC50 value. Both 20-I-14,15-EE8ZE agonist activities were blocked by the EET antagonist 14,15-epoxyeicosa-5(Z)-enoic acid (14,15-EE5ZE). Specific 20-125I-14,15-EE8ZE binding to U937 membranes reached equilibrium within 10 min and remained unchanged for 30 min at 4° C. The binding was saturable, reversible, and exhibited KD and Bmax values of 11.8 ± 1.1 nM and 5.8 ± 0.2 pmol/mg protein, respectively. Pretreatment of the membranes with guanosine 5′-O-(3-thio)triphosphate reduced the Bmax in a concentration-related manner. 20- 125I-14,15-EE8ZE binding was inhibited by eicosanoids with potency order of 11,12-EET >14,15-EE5ZE ≈ 14,15-EET ≫ 15- hydroxyeicosatetraenoic acid > 14,15-EET-thiirane >14,15- dihydroxyeicosatrienoic acid. This order is in agreement with the efficacy and potency of cAMP production. In summary, 20-125I-14,15-EE8ZE is a radiolabeled EET agonist that is useful to study binding and metabolism. Using this radioligand, we have identified a specific high-affinity and high-abundance EET binding site in U937 cell membranes. This binding site could represent a specific EET receptor, which is probably a G protein-coupled receptor.

AB - Epoxyeicosatrienoic acids (EETs) are important regulators of vascular tone and homeostasis. Whether they initiate signaling through membrane receptors is unclear. We developed 20-iodo-14,15-epoxyeicosa-8(Z)-enoic acid (20-I-14,15-EE8ZE), a radiolabeled EET agonist, to characterize EET binding to membranes of U937 cells. 20-I-14,15-EE8ZE stimulated cAMP production in U937 cells with similar potency, but it decreased efficacy compared with 11,12-EET. Maximum cAMP production increased 4.2-fold, with an EC50 value of 9 μM. Like 14,15-EET, 20-I-14,15-EE8ZE relaxed bovine coronary arteries, with a similar EC50 value. Both 20-I-14,15-EE8ZE agonist activities were blocked by the EET antagonist 14,15-epoxyeicosa-5(Z)-enoic acid (14,15-EE5ZE). Specific 20-125I-14,15-EE8ZE binding to U937 membranes reached equilibrium within 10 min and remained unchanged for 30 min at 4° C. The binding was saturable, reversible, and exhibited KD and Bmax values of 11.8 ± 1.1 nM and 5.8 ± 0.2 pmol/mg protein, respectively. Pretreatment of the membranes with guanosine 5′-O-(3-thio)triphosphate reduced the Bmax in a concentration-related manner. 20- 125I-14,15-EE8ZE binding was inhibited by eicosanoids with potency order of 11,12-EET >14,15-EE5ZE ≈ 14,15-EET ≫ 15- hydroxyeicosatetraenoic acid > 14,15-EET-thiirane >14,15- dihydroxyeicosatrienoic acid. This order is in agreement with the efficacy and potency of cAMP production. In summary, 20-125I-14,15-EE8ZE is a radiolabeled EET agonist that is useful to study binding and metabolism. Using this radioligand, we have identified a specific high-affinity and high-abundance EET binding site in U937 cell membranes. This binding site could represent a specific EET receptor, which is probably a G protein-coupled receptor.

UR - http://www.scopus.com/inward/record.url?scp=40849139451&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40849139451&partnerID=8YFLogxK

U2 - 10.1124/jpet.107.129577

DO - 10.1124/jpet.107.129577

M3 - Article

C2 - 18171909

AN - SCOPUS:40849139451

VL - 324

SP - 1019

EP - 1027

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 3

ER -